原稿のタイトル: チュニジアにおける標的型抗がん治療の消費と支出の動向
Farah Allani1, Sarah Zerei1, Skander Daghfous2
1Ministry of health -Department: ANMPS. Tunisia; Faculty of Pharmacy, 5000 Monastir, Tunisia.
Journal of cancer policy
|February 20, 2026
まとめ
チュニジアは,標的型抗がん療法費用の課題に直面しています. 医薬品経済評価や地元の製造などの戦略は,これらの重要ながん薬の持続可能なアクセスを確保する上で鍵となるものです.
科学分野:
- 腫瘍学 腫瘍学
- 健康経済学 医療経済学
- 医薬品政策について
背景:
- 標的型抗がん療法により,がん治療は変化したが,チュニジアでは医療費が増加した.
- 消費と支出の国内動向を分析することは,これらの財政負担の管理に不可欠です.
研究 の 目的:
- 2010年から2021年までのチュニジアにおける標的型抗がん療法の消費と支出の国内動向を分析する.
- これらの傾向に影響を与える要因を特定し,持続可能なアクセスのための政策解決策を提示する.
主な方法:
- 国家データ (2010年-2021年) の遡及分析.
- 支出の評価,消費量,治療用クラスの分布,および市場認可の状況.
主要な成果:
- 消費量は増加し,支出は88% (2010年-2017年) 増加し,モノクローナル抗体が優勢でした.
- 消費が増加したにもかかわらず,支出は15% (2017-2020) 減少し,モノクローナル抗体とチロシンキナーゼ阻害剤の市場シェアがよりバランスの取れた.
- 市場認可の増加,バイオシミラー/ジェネリック薬の普及 (2014年以降) および現地製造の影響を受けた傾向.
結論:
- チュニジアは,ターゲットを絞った抗がん療法へのアクセスを財政的持続可能性とバランスをとるという課題に直面しています.
- 医薬品経済戦略,継続的な評価,価格の見直し,地元の製造を促進することは,持続可能で公平なアクセスを確保するために不可欠です.
キーワード:
バイオシミラーとジェネリック医薬品薬物へのアクセス 薬物へのアクセス薬物消費 薬物消費 薬物消費支出 支出についてモノクローナル抗体腫瘍学薬剤は,腫瘍学における薬剤である.薬学経済学 薬学経済学ターゲットを絞った抗がん療法タイロシンキナーゼ阻害剤 タイロシンキナーゼ阻害剤さらに関連する動画
09:49Dual-phase Cone-beam Computed Tomography to See, Reach, and Treat Hepatocellular Carcinoma during Drug-eluting Beads Transarterial Chemo-embolization
Published on: December 2, 2013
10.8K
09:44Pretargeted Radioimmunotherapy Based on the Inverse Electron Demand Diels-Alder Reaction
Published on: January 29, 2019
10.6K
関連する概念動画
02:57Targeted Cancer Therapies
9.0K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
9.0K
02:49Cancer Therapies
10.2K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
10.2K
02:18Cancer
54.8K
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
54.8K
02:56Treatment Resistant Cancers
3.8K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.8K
01:21Cancer Survival Analysis
793
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
793
01:29Therapeutic Drug Monitoring: Affecting Factors
266
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
266